609580 20
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 609580 20, covering 2011-02-03 to 2011-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis [NA]